USD
GBP
CNY
EUR
INR
JPY
MYR
ZAR
KRW
THB
U.S. Emerging Melanoma Therapeutics Market
U.S. Emerging Melanoma Therapeutics Market
RELEASE DATE
03-Oct-2001
03-Oct-2001
REGION
North America
North America
Research Code: A090-01-00-00-00
SKU: HC00800-NA-MR_04475
$2,450.00
Special Price $1,837.50 save 25 %
In stock
SKU
HC00800-NA-MR_04475
Description
This report on the U.S. Emerging Melanoma Therapeutics Market gives a detailed overview of the existing, as well as the emerging markets. The report identifies and discusses major market drivers and restraints, as well as challenges facing the industry and offers strategies to address these challenges. Key market and technology trends are discussed relative to the future of the market. The market is segmented by product class, namely chemotherapeutics and immunotherapeutics. For each segment, the report provides information about existing and emerging products, revenue forecasts, market shares and pricing trends.
Table of Contents
Executive Summary
- Executive Summary
Overview
- Scope and Segmentation
- Types of Melanoma
- Epidemiology
- Etiology
- Staging
- Treatment Of Localized Melanoma
- Treatment Of Regional Melanoma
- Treatment Of Metastatic Melanoma
- Treatment Of Recurrent Melanoma And Survival Rates
- Demand Analysis
- Market and Technology Trends
- Challenges
- Market Drivers
- Market Restraints
Strategic Recommendations
- Strategies Overview
- Strategic Recommendations for Market Challenge 1
- Strategic Recommendations for Market Challenge 2
- Strategic Recommendations for Market Challenge 3
- Strategic Recommendations for Market Challenge 4
- Strategic Recommendations for Market Challenge 5
Frost & Sullivan Market Engineering Awards
- Strategic Alliance Leadership Award : Therion Biologics Corporation
- Merger And Acquisition Award : Corixa Corporation
- Technology Leadership Award : Genzyme Molecular Oncology
- Technology Innovation Award : Protarga Inc
Overview
Forecasts and Trends
Competitive Analysis
- Introduction
- Market Engineering Analysis
Overview
Forecasts and Trends
Competitive Analysis
Popular Topics
This report on the U.S. Emerging Melanoma Therapeutics Market gives a detailed overview of the existing, as well as the emerging markets. The report identifies and discusses major market drivers and restraints, as well as challenges facing the industry and offers strategies to address these challenges. Key market and technology trends are discussed relative to the future of the market. The market is segmented by product class, namely chemotherapeutics and immunotherapeutics. For each segment, the report provides information about existing and emerging products, revenue forecasts, market shares and pricing trends.
| No Index | Yes |
|---|---|
| Podcast | No |
| Industries | Healthcare |
| WIP Number | A090-01-00-00-00 |
| Is Prebook | No |